U
CORT icon

UBS’s Corcept Therapeutics CORT Stock Holding History

UBS’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$359K Sell
134,131
-21,000
-14% -$55.6K ﹤0.01% 4598
2014
Q2 		$434K Sell
155,131
-5,000
-3% -$14.8K ﹤0.01% 4359
2014
Q1 		$698K Sell
160,131
-4,151
-3% -$14.5K ﹤0.01% 3883
2013
Q4 		$527K Buy
164,282
+1,440
+0.9% +$2.91K ﹤0.01% 4272
2013
Q3 		$259K Sell
162,842
-45,712
-22% -$80.6K ﹤0.01% 4863
2013
Q2 		$361K Buy
+208,554
New +$375K ﹤0.01% 4442

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCA
Catalyst Capital Advisors Huntington, New York $5.37B AUM 18.53% 1-Year Est. Return